Fusion Pharmaceuticals Inc. Deferred Revenue
Fusion Pharmaceuticals Inc. had Deferred Revenue of $333.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2024-05-07
- 2024-03-31: Deferred Revenue, Current $333.00K.
- 2023-12-31: Deferred Revenue, Current $333.00K.
- 2023-09-30: Deferred Revenue, Current $333.00K.
- 2023-06-30: Deferred Revenue, Current $333.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2024-03-31 | $333.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $333.00K 10-Q · filed 2024-05-07 |
| 2023-09-30 | $333.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $333.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $333.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $333.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $412.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $707.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.10M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.54M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.29M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.73M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.00M 10-K · filed 2022-03-17 |